Neuralink
Neuralink is developing brain-computer interfaces, specifically brain chips, designed to help individuals with paralysis. The company's technology has made significant progress, including human clinical trials and receiving breakthrough device designation from the FDA.
Funding Round: Series E
Funding Amount: $650M
Date: 02-Jun-2025
Investors: ARK Invest, Founders Fund, Sequoia Capital, Thrive Capital
Markets: Healthtech, Biotechnology Research, Medical, Neuroscience, Robotics
HQ: Fremont, California, United States
Founded: 2016
Website: https://neuralink.com/
LinkedIn: https://www.linkedin.com/company/neuralink
Twitter: https://twitter.com/neuralink
Facebook: https://www.facebook.com/Neuralink-105959564083517
Crunchbase: https://www.crunchbase.com/organization/neuralink
Leave a Comment
Comments
No comments yet.